Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.06% | 11.69% | 19.71% | 26.78% | 16.94% |
| Total Depreciation and Amortization | 16.47% | 8.46% | 7.95% | 9.01% | 14.02% |
| Total Amortization of Deferred Charges | -53.09% | 23.29% | 23.29% | 23.29% | -0.24% |
| Total Other Non-Cash Items | -336.34% | 180.04% | 242.21% | 208.43% | 182.36% |
| Change in Net Operating Assets | 45.71% | -666.09% | -53.53% | 0.34% | 4.95% |
| Cash from Operations | 14.26% | 11.99% | 24.09% | 35.56% | 23.06% |
| Capital Expenditure | -2.29% | 38.16% | 36.71% | 41.72% | 7.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 79.04% | 100.88% | 103.43% | 101.57% | -488.69% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.58% | 42.87% | 47.80% | 24.16% | 52.12% |
| Cash from Investing | 55.97% | 79.80% | 81.34% | 77.24% | -83.33% |
| Total Debt Issued | -8.26% | -51.68% | -51.68% | -113.79% | 525.35% |
| Total Debt Repaid | -121.49% | -57.12% | -118.72% | -20.44% | -10.14% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.51% | -1,850.72% | -1,171.15% | -1,171.01% | -1,171.01% |
| Cash from Financing | -1,397.62% | -374.12% | -298.71% | -279.57% | 114.07% |
| Foreign Exchange rate Adjustments | 230.44% | -92.49% | 348.45% | 119.45% | -1,721.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.98% | 92.32% | 184.40% | 354.49% | 439.53% |